Christopher Cook
Senior Hematology Consultant @Servier Pharmaceuticals
Signup · Get unlimited contacts
WORK HISTORY
Senior Hematology Consultant @Servier Pharmaceuticals
Dallas-Fort Worth, TX, US
Promotion of Tibsovo (ivosidenib) for mIDH-1 AML and launch and promotion of Tibsovo relapsed/refractory cholangiocarcinoma-Promotion of Oncaspar/Asparlas for pediatric/AYA Acute Lymphoblastic Leukemia-Successfully launched Tibsovo in relapsed/refractory AML, first line AML mono therapy, first line AML in combination with azacitadine, relapsed/refractory cholangiocarcinoma, and relapsed/refractory MDS-2022 Winner of peer nominated Gold Award-2023 Winner of ACE National Sales Award (Ranked #1 out of 35••••••22 member of FASO (Field Adviser to Sales Operations) team-20••••21 member of FAST (Field Adviser to Sales Training) team-served on senior leadership QBR (quarterly business review)(April 2022) in absence of regional business director-served on hiring panels to interview representatives and regional business directors-consistent quarter over quarter growth for Tibsovo since launch with exception of Q2/3 2020 (after COVID)-nominated by RBD to represent company at major national congresses/conferences (ASH, ASCO, HOPA, SOHO) on multiple occasions.
EDUCATION
Hendrix College
Bachelor of Arts
SKILLS
ABOUT CHRISTOPHER COOK
As a Senior Hematology Consultant at Servier Pharmaceuticals, I have over 8 years of…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.